Canine degenerative myelopathy: Biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model

Experimental Neurology

Volumn 248, Issue , 2013, Pages 1-9

  Crisp, Matthew J ^a   Beckett, Jeffrey ^a   Coates, Joan R ^b   Miller, Timothy M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DIMER;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CANINE DEGENERATIVE MYELOPATHY; CONTROLLED STUDY; DISEASE COURSE; DOG; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME CHEMISTRY; GENE LOCATION; HUMAN VERSUS ANIMAL COMPARISON; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; SPINAL CORD; SPINAL CORD DISEASE;

ALS; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE MYELOPATHY; DM; GENOME-WIDE ASSOCIATION STUDY; GWAS; IPTG; ISOPROPYL-Β-D-1-THIOGALACTOPYRANOSIDE; SOD1; SUPEROXIDE DISMUTASE 1; TFE; TRIFLUOROETHANOL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE PROGRESSION; DOG DISEASES; DOGS; MUTATION; SPINAL CORD; SUPEROXIDE DISMUTASE; THORACIC VERTEBRAE;

EID: 84879360499     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.05.009     Document Type: Article

References (35)

1. Awano T., Johnson G.S., Wade C.M., Katz M.L., Johnson G.C., Taylor J.F., Perloski M., Biagi T., Baranowska I., Long S., March P.A., Olby N.J., Shelton G.D., Khan S., O'Brien D.P., Lindblad-Toh K., Coates J.R. Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2794-2799.
2. Borchelt D.R., Lee M.K., Slunt H.S., Guarnieri M., Xu Z.S., Wong P.C., Brown R.H., Price D.L., Sisodia S.S., Cleveland D.W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8292-8296.
3. Bruijn L.I. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281:1851-1854.
4. Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma×spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992, 194:209-221.
5. Chia R., Tattum M.H., Jones S., Collinge J., Fisher E.M., Jackson G.S. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One 2010, 5:e10627.
6. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003, 424:805-808.
7. Coates J.R., Wininger F.A. Canine degenerative myelopathy. Vet. Clin. North Am. Small Anim. Pract. 2010, 40:929-950.
8. Coates J.R., March P.A., Oglesbee M., Ruaux C.G., Olby N.J., Berghaus R.D., O'Brien D.P., Keating J.H., Johnson G.S., Williams D.A. Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs. J. Vet. Intern. Med. 2007, 21:1323-1331.
9. Deng H.X., Shi Y., Furukawa Y., Zhai H., Fu R., Liu E., Gorrie G.H., Khan M.S., Hung W.Y., Bigio E.H., Lukas T., Dal Canto M.C., O'Halloran T.V., Siddique T. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7142-7147.
10. Flood D.G., Reaume A.G., Gruner J.A., Hoffman E.K., Hirsch J.D., Lin Y.G., Dorfman K.S., Scott R.W. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am. J. Pathol. 1999, 155:663-672.
11. Gomes C., Escrevente C., Costa J. Mutant superoxide dismutase 1 overexpression in NSC-34 cells: effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins. Neurosci. Lett. 2010, 475:145-149.
12. Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O'Neill M.A., Gibbs E., Semenchenko V., Yousefi M., Wishart D.S., Plotkin S.S., Cashman N.R. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16398-16403.
13. Green S.L., Tolwani R.J., Varma S., Quignon P., Galibert F., Cork L.C. Structure, chromosomal location, and analysis of the canine Cu/Zn superoxide dismutase (SOD1) gene. J. Hered. 2002, 93:119-124.
14. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
15. Kostrominova T.Y. Advanced age-related denervation and fiber-type grouping in skeletal muscle of SOD1 knockout mice. Free Radic. Biol. Med. 2010, 49:1582-1593.
16. Matsumoto G., Stojanovic A., Holmberg C.I., Kim S., Morimoto R.I. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J. Cell Biol. 2005, 171:75-85.
17. Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts L.J., Csete M., Faulkner J.A., Van Remmen H. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 2006, 40:1993-2004.
18. Münch C., Bertolotti A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J. Mol. Biol. 2010, 399:512-525.
19. Munch C., O'Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3548-3553.
20. Prudencio M., Durazo A., Whitelegge J.P., Borchelt D.R. Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J. Neurochem. 2009, 108:1009-1018.
21. Prudencio M., Hart P.J., Borchelt D.R., Andersen P.M. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum. Mol. Genet. 2009, 18:3217-3226.
22. Prudencio M., Durazo A., Whitelegge J.P., Borchelt D.R. An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum. Mol. Genet. 2010, 19:4774-4789.
23. Ramesh T., Lyon A.N., Pineda R.H., Wang C., Janssen P.M., Canan B.D., Burghes A.H., Beattie C.E. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis. Model Mech. 2010, 3:652-662.
24. Rankin K.S., Starkey M., Lunec J., Gerrand C.H., Murphy S., Biswas S. Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma. Pediatr. Blood Cancer 2012, 58:327-333.
25. Ratovitski T., Corson L.B., Strain J., Wong P., Cleveland D.W., Culotta V.C., Borchelt D.R. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum. Mol. Genet. 1999, 8:1451-1460.
26. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:689-693.
27. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
28. Rowell J.L., McCarthy D.O., Alvarez C.E. Dog models of naturally occurring cancer. Trends Mol. Med. 2011, 17:380-388.
29. Shefner J.M., Reaume A.G., Flood D.G., Scott R.W., Kowall N.W., Ferrante R.J., Siwek D.F., Upton-Rice M., Brown R.H. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 1999, 53:1239-1246.
30. Shelton G.D., Johnson G.C., O'Brien D.P., Katz M.L., Pesayco J.P., Chang B.J., Mizisin A.P., Coates J.R. Degenerative myelopathy associated with a missense mutation in the superoxide dismutase 1 (SOD1) gene progresses to peripheral neuropathy in Pembroke Welsh Corgis and Boxers. J. Neurol. Sci. 2012, 318:55-64.
31. Tiwari A., Hayward L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 2003, 278:5984-5992.
32. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008, 85:94-134.
33. Wang J., Slunt H., Gonzales V., Fromholt D., Coonfield M., Copeland N.G., Jenkins N.A., Borchelt D.R. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 2003, 12:2753-2764.
34. Wininger F.A., Zeng R., Johnson G.S., Katz M.L., Johnson G.C., Bush W.W., Jarboe J.M., Coates J.R. Degenerative myelopathy in a Bernese Mountain Dog with a novel SOD1 missense mutation. J. Ve.t Intern. Med. 2011, 25:1166-1170.
35. Zetterstrom P., Stewart H.G., Bergemalm D., Jonsson P.A., Graffmo K.S., Andersen P.M., Brannstrom T., Oliveberg M., Marklund S.L. Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14157-14162.